These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 33037410)
1. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia. Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410 [TBL] [Abstract][Full Text] [Related]
2. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia. Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381 [TBL] [Abstract][Full Text] [Related]
3. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation. Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052 [TBL] [Abstract][Full Text] [Related]
4. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape. Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154 [TBL] [Abstract][Full Text] [Related]
5. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia. Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834 [TBL] [Abstract][Full Text] [Related]
6. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Bernt KM; Zhu N; Sinha AU; Vempati S; Faber J; Krivtsov AV; Feng Z; Punt N; Daigle A; Bullinger L; Pollock RM; Richon VM; Kung AL; Armstrong SA Cancer Cell; 2011 Jul; 20(1):66-78. PubMed ID: 21741597 [TBL] [Abstract][Full Text] [Related]
7. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896 [TBL] [Abstract][Full Text] [Related]
8. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. Nguyen AT; Taranova O; He J; Zhang Y Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783 [TBL] [Abstract][Full Text] [Related]
9. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression. Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822 [TBL] [Abstract][Full Text] [Related]
10. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551 [TBL] [Abstract][Full Text] [Related]
11. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome. Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946 [TBL] [Abstract][Full Text] [Related]
12. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597 [TBL] [Abstract][Full Text] [Related]
13. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232 [TBL] [Abstract][Full Text] [Related]
14. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506 [TBL] [Abstract][Full Text] [Related]
15. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia. Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727 [TBL] [Abstract][Full Text] [Related]
16. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis. Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462 [TBL] [Abstract][Full Text] [Related]
18. Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation. Wang F; Li Z; Wang G; Tian X; Zhou J; Yu W; Fan Z; Dong L; Lu J; Xu J; Zhang W; Liang A Mol Med Rep; 2020 Feb; 21(2):883-893. PubMed ID: 31789407 [TBL] [Abstract][Full Text] [Related]